The Barcelona Debates on the Human Microbiome 2019

Microbiome
On-site
English
Museo de la Ciencia CosmoCaixa

Status

Activity finished

Price

Free

Do you want to know the next activities activities on Microbiome?

Join our newsletter list to be updated on upcoming activitie

Information

The 2019 “Barcelona Debates on the Human Microbiome. From Microbes to Medicines” will discuss the most recent studies on the complex human-microbiome relationship & how the microbiome can influence in improving health and well-being of people, and will explore future research areas in this promising field. The 2-day meeting brings together international leading-edge research scientists and practitioners, and has become a meeting of reference.

Our body has millions of microbes, referred to generally as our microbiome or microbiota. More than 99% of “our” genetic information comes from information contained in the millions of microbes that inhabit our bodies. Understanding human-microbiome and how it can be modulated is a challenge and a great opportunity as it exerts an enormous influence on our health. With the participation of leading investigators in human microbiome research, “The 2019 Barcelona Debates on the Human Microbiome. From Microbes to Medicines” will discuss the more recent studies on the complex human-microbiome relationship, how the microbiome can influence in improving the health and well-being and explore future research areas on this promising field.

Program:

Download the program

Coordinators

Bonaventura Clotet

President of the Fight Infections Foundation and Director of the IrsiCaixa AIDS Research Institute

Fundació Lluita contra les Infeccions, Badalona, Spain. Institut d'Investigació del Sida IrsiCaixa i Institut Català de la Salut, Badalona, Spain.

Bonaventura Clotet

President of the Fight Infections Foundation and Director of the IrsiCaixa AIDS Research Institute

Dr. Clotet received his MD (1976) and his PhD (1981), with a thesis on autoimmune diseases, from the Autonomous University of Barcelona (UAB). That same year, his internship as an Internal Medicine specialist at the Vall d’Hebron University Hospital in Barcelona coincided with the first AIDS case reported in Spain. This case was the catalyst for a career dedicated to this serious disease, first as head of the HIV Unit of the Germans Trias i Pujol University Hospital in Badalona (1987-2015) and then as founder and president of the Fight against AIDS Foundation (1992), which is now named as Fight Infections Foundation.

Dr. Clotet soon saw the need to go a step beyond patient care to conduct research aimed at eradicating AIDS. In 1995, with the support of “la Caixa” and the Department of Health of the Generalitat of Catalonia, he founded the IrsiCaixa AIDS Research Institute, which he still heads. In addition, Dr. Clotet is also the clinical director of Infectious Diseases at the Metropolitana Nord area of the Catalan Institute of Health, scientific advisor to two IrsiCaixa spin-offs: Aelix Therapeutics SL and AlbaJuna Therapeutics SL and director of the Chair of AIDS and Related Diseases at the Universitat de Vic (UVic).

He has published more than 1000 papers in high impact international journals and his contributions to research have been recognized with the Josep Trueta medal to Sanitary Merit and the ‘Premi Nacional de Recerca’, among other awards.
Francisco Guarner

Constultant of gastroenterology

Teknon Medical Centre, Barcelona.

Francisco Guarner

Constultant of gastroenterology

Consultant of Gastroenterology, Teknon Medical Centre Barcelona. International Human Microbiome Consortium Steering Committee Member. President of the Probiotics and Prebiotics Spanish Society Board. World Gastroenterology Organization
Roger Paredes

Head of the Infectious Diseases Service

Fight Infections Foundation. Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Roger Paredes

Head of the Infectious Diseases Service

Roger Paredes, MD, PhD, is the Head of the Infectious Diseases Service at Hospital Universitari Germans Trias i Pujol, Head of the Microbial Genomics Group at the IrsiCaixa AIDS Research Institute, Badalona, Spain.

Roger Paredes obtained an MD, PhD degree in Medicine and Surgery from the Autonomous University of Barcelona (UAB). He specialised in HIV resistance at the Brigham & Women’s Hospital in Boston and Harvard Medical School. His team has demonstrated the clinical utility of HIV-1 deep sequencing in both high- and low-income countries.